Montecito Bank & Trust’s iShares iBonds Dec 2032 Term Corporate ETF IBDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.11M Buy
45,943
+1,524
+3% +$37.7K 0.17% 126
2026
Q2
$1.12M Buy
44,419
+1,221
+3% +$30.8K 0.17% 128
2026
Q1
$1.09M Buy
43,198
+9,798
+29% +$250K 0.18% 125
2025
Q4
$853K Buy
33,400
+8,495
+34% +$217K 0.14% 145
2025
Q3
$638K Buy
+24,905
New +$632K 0.1% 185
2025
Q1
$706K Buy
28,265
+280
+1% +$6.93K 0.13% 167
2024
Q4
$688K Hold
27,985
– – 0.12% 169
2024
Q3
$719K Buy
27,985
+9,660
+53% +$244K 0.12% 166
2024
Q2
$450K Buy
18,325
+6,151
+51% +$150K 0.09% 194
2024
Q1
$302K Buy
+12,174
New +$302K 0.06% 234

Other funds holding IBDX

Montecito Bank & Trust's IBDX Position: Q3 2026 in Review

Montecito Bank & Trust increased its iShares iBonds Dec 2032 Term Corporate ETF (IBDX) stake by 3.4% in Q3 2026, buying an estimated $37.7K and bringing the position to 45,943 shares worth $1.11M. The position accounts for 0.17% of the portfolio, ranked #126.

Montecito Bank & Trust first reported a position in IBDX in Q1 2024 and has held it in 10 quarters since. The position peaked at $1.12M in Q2 2026. 70 funds tracked by Wall St. Rank hold IBDX as of Q3 2026.

  • Montecito Bank & Trust held 45,943 shares of iShares iBonds Dec 2032 Term Corporate ETF worth $1.11M as of Q3 2026.
  • Montecito Bank & Trust bought 1,524 iShares iBonds Dec 2032 Term Corporate ETF shares in Q3 2026, an estimated $37.7K.
  • iShares iBonds Dec 2032 Term Corporate ETF made up 0.17% of Montecito Bank & Trust's portfolio in Q3 2026, its #126 holding.
  • Montecito Bank & Trust first reported a position in iShares iBonds Dec 2032 Term Corporate ETF in Q1 2024 and has held it in 10 quarters since.
  • Montecito Bank & Trust's iShares iBonds Dec 2032 Term Corporate ETF position peaked at $1.12M in Q2 2026.
  • 70 funds tracked by Wall St. Rank held iShares iBonds Dec 2032 Term Corporate ETF as of Q3 2026.

Based on Montecito Bank & Trust's 13F filing for Q3 2026, filed 1 Oct 2026.